Instalab
logoInstalab

3-Hydroxypropionic Acid

Urine Test
A clue to inherited disorders that can cause dangerous acid buildup during illness or fasting.
4.9 (3,296 reviews)
Tested by Genova Diagnostics
Physician-reviewed results
Results in under 1 week
How it works
Order from Instalab
No prescription or your own doctor's order needed
Self-collect at home
Kit shipped directly to you
Get results
Explained with clear next steps, no medical jargon

Should you take a 3-Hydroxypropionic Acid test?

This test is most useful if any of these apply to you.

Following Up an Unusual Organic Acid Result
An unexpected result can be assessed alongside related acids to help identify its cause.
Concerned About Metabolic Disease in Your Family
A family history can justify targeted evaluation; urine testing complements genetic testing for the known family disorder.
Having Unexplained Episodes After Fasting or Illness
Recurrent vomiting or unusual drowsiness can warrant metabolic evaluation; severe symptoms need urgent care.
Living With Propionic or Methylmalonic Acidemia
This result can support follow-up alongside symptoms and other tests, but it cannot reliably predict a crisis.

About 3-Hydroxypropionic Acid

Urinary 3-hydroxypropionic acid helps identify disorders in how your body processes certain amino acids and fats. Small amounts occur normally. Larger amounts, especially alongside a characteristic pattern of other urine acids, can point to inherited conditions such as propionic acidemia or methylmalonic acidemia. Some of these conditions can cause dangerous acid and ammonia buildup.

Its role in investigating inherited metabolic disease is established. Its use as a general wellness marker is exploratory. A result doesn't measure how thoroughly you digest protein, diagnose a gut bacterial imbalance, or establish how well your mitochondria are working. Mitochondria are the structures inside cells that produce much of their usable energy. There is no validated longevity target for this urine acid.

Where the Acid Comes From

Your body produces propionyl-CoA while breaking down certain amino acids and fats. Amino acids are the building blocks of protein. Sources include valine, isoleucine, methionine, and threonine, along with fats that have an odd number of carbon atoms. Propionate made by gut bacteria also feeds this pathway.

An enzyme called propionyl-CoA carboxylase normally processes propionyl-CoA with help from biotin. A later step requires vitamin B12 and produces a compound that can enter energy-producing reactions. When this pathway is impaired, more material can enter a side route that produces 3-hydroxypropionic acid. Human tracer experiments showed that labeled propionate and valine could appear in urine as this acid.

Propionic Acidemia

In propionic acidemia, inherited changes reduce the activity of propionyl-CoA carboxylase. Babies can become seriously ill within days of birth, though some people first develop symptoms later. Urine commonly contains increased 3-hydroxypropionic acid and methylcitric acid without the methylmalonic acid increase characteristic of methylmalonic acidemia.

There is some evidence connecting urine levels with long-term outcomes in people who already have this diagnosis. A French study followed 80 patients with organic acid disorders, including 24 with propionic acidemia. Each doubling of average urinary 3-hydroxypropionic acid during the first six years was associated with about fivefold higher odds of a severe neurological outcome. This was a small retrospective analysis, so it doesn't show that lowering the urine value itself prevents neurological injury.

A separate natural history study of 50 people with propionic acidemia measured 3-hydroxypropionic acid in plasma, a different measurement from this urine result. One statistical model associated a plasma concentration half as high with about 30% fewer metabolic crises. Another model did not establish a clear association. These findings support further study of plasma levels, but they don't establish a corresponding reduction in risk from lowering your urine result.

Methylmalonic Acidemia

Methylmalonic acidemia involves a later part of the same pathway. It can result from a defect in the B12-dependent enzyme or in the machinery that processes vitamin B12 inside cells. Methylmalonic acid is the main biochemical finding; 3-hydroxypropionic acid and methylcitric acid can also increase.

The combination of acids helps distinguish these disorders, but it doesn't establish the exact cause. Acquired vitamin B12 deficiency can also raise methylmalonic acid. Some inherited B12-processing disorders occur despite a normal blood vitamin B12 concentration, so that result alone cannot exclude them.

Biotin-Related Enzyme Disorders

Several enzymes need biotin to function. Holocarboxylase synthetase deficiency interferes with attaching biotin to those enzymes, while biotinidase deficiency interferes with recycling it. Both can affect several metabolic pathways at once. In a series of 28 people with holocarboxylase synthetase deficiency, urinary 3-hydroxypropionic acid increased alongside methylcitric acid and other organic acids.

Mild nutritional biotin deficiency is a different question. In experiments involving 21 healthy adults made marginally biotin deficient, urinary 3-hydroxypropionic acid identified only five. Urinary 3-hydroxyisovaleric acid was more sensitive. A normal result here therefore doesn't rule out mild biotin deficiency.

Other Rare Enzyme Defects

Rare defects in other breakdown pathways can produce similar findings. Impaired processing of compounds called semialdehydes has been reported with increased urinary 3-hydroxypropionic acid, beta-alanine, and related acids. In succinic semialdehyde dehydrogenase deficiency, the main abnormality involves the breakdown of a brain signaling chemical, but urinary 3-hydroxypropionic acid can also increase. The accompanying compounds are necessary to distinguish these conditions.

When Gut Bacteria May Contribute

Gut bacteria can contribute to the material entering this pathway, and unusual bacterial metabolism may sometimes contribute directly to urinary 3-hydroxypropionic acid. A historical report described four severely ill people with large amounts of this acid and propan-1,3-diol in urine. Propionyl-CoA carboxylase activity was normal in the two people whose skin cells were tested. The authors inferred a bacterial source.

That report doesn't establish how often gut bacteria explain an isolated increase in otherwise healthy adults. A modest increase with digestive symptoms cannot, by itself, diagnose a bacterial imbalance or identify which organism is responsible.

Research in children with tuberculous meningitis also found altered urinary 3-hydroxypropionic acid. The study included 35 affected children and 40 controls and used a research method that reported relative chemical signals. The authors proposed a connection with gut bacterial metabolism, but the urine findings did not establish the source. This has not become a validated test for tuberculosis or gut bacterial imbalance.

What Lower Results Mean

Lower urinary values have appeared in small studies of other conditions. Women with intrahepatic cholestasis of pregnancy had about two-thirds less urinary 3-hydroxypropionic acid than healthy pregnant women in a small study. This pregnancy-related liver condition impairs bile flow and can cause intense itching. The targeted analysis included only 10 affected and 10 unaffected women, mostly the same participants used in the discovery analysis. It was not an independent validation.

An exploratory study involving 11 children with sleep disorders found a lower urinary 3-hydroxypropionic acid signal in moderate sleep apnea than in mild sleep apnea. That study compared relative amounts within a research profile, which cannot be read as equivalent to a clinical concentration adjusted for urine dilution.

Neither finding establishes a low-result disorder or a screening role for this test. In a healthy adult, there is no evidence-based reason to try to raise a low result or push an already low result further down.

Kidney Research Has a Measurement Limitation

A study of about 1,000 adults with diabetes and chronic kidney disease reported kidney-risk associations for a urine signal labeled 3-hydroxypropionate. It used 24-hour urine collections and a research method that could not distinguish this compound from lactate. Those findings therefore cannot establish that this clinical 3-hydroxypropionic acid measurement predicts kidney decline.

When Results Can Be Misleading

Clinical urine organic acid analysis separates compounds and identifies their chemical signatures using gas chromatography-mass spectrometry, commonly called GC-MS. Quantitative results are usually compared with urine creatinine to account for dilution. Interpretation still depends on the full chemical pattern and the circumstances of collection.

  • Fasting and illness: these can increase the breakdown of the body's own tissues. Prolonged fasting increased urinary pathway metabolites in children with propionic or methylmalonic acidemia. This is a real biological change and may make an underlying disorder easier to detect.
  • A sample collected while well: some metabolic abnormalities become less apparent between episodes. A reassuring result cannot always exclude a disorder when symptoms or family history remain concerning.
  • Urine dilution and age: creatinine adjustment helps account for dilution, but very dilute samples and age-related differences can still complicate interpretation, particularly in infants and children.
  • Treatment and recent medication: biotin, B12-based treatment, and antibiotics can alter the metabolic pattern in particular disorders. The result needs to be interpreted alongside what you were taking.
  • Storage and contamination: bacterial growth in an improperly stored sample can change its organic acid pattern.
  • Different reporting methods: a qualitative profile, a quantitative urine concentration, a research signal, and a plasma concentration are different kinds of results. Their numbers cannot be treated as interchangeable.

Tracking Your Trend

If you have a diagnosed metabolic disorder, repeated urine results can provide supporting information alongside symptoms and other biochemical tests. The classic organic acid markers do not always change in step with an acute crisis. A falling urine value alone cannot establish that treatment is adequate or that neurological or heart complications have been prevented.

For a healthy adult, changes over time have no validated interpretation as a measure of improved protein processing, mitochondrial function, or longevity. A personal baseline doesn't resolve that uncertainty.

What Moves This Biomarker

Evidence-backed interventions that affect your 3-Hydroxypropionic Acid level

↓ Decrease
Liver transplantation for propionic acidemia
A transplanted liver provides functioning enzyme activity. In a retrospective study of 39 children with propionic acidemia, the median urinary 3-hydroxypropionic acid value fell by about 97% six months after transplantation, with improved metabolic stability. Transplantation is major surgery requiring long-term anti-rejection medication and does not cure the enzyme defect in other tissues.
ProcedureStrong Evidence
↓ Decrease
High-dose biotin treatment for holocarboxylase synthetase deficiency
Biotin-based treatment substantially reduced urinary 3-hydroxypropionic acid and other abnormal metabolites in a retrospective series of 28 people with holocarboxylase synthetase deficiency. Promptly treated survivors had favorable clinical outcomes. This is treatment for a confirmed biotin-related enzyme disorder, not evidence that biotin benefits everyone with an increased result.
SupplementStrong Evidence
↓ Decrease
Hydroxocobalamin, betaine, and folate treatment for cobalamin C deficiency
In an adolescent with genetically confirmed cobalamin C deficiency, injected hydroxocobalamin together with betaine and folate markedly reduced urinary 3-hydroxypropionic acid and improved symptoms. This disorder impairs vitamin B12 processing inside cells and can occur despite a normal blood B12 concentration.
MedicationStrong Evidence
↓ Decrease
Intermittent metronidazole added to dietary treatment for methylmalonic acidemia
In eight people with genetically confirmed methylmalonic acidemia, adding intermittent metronidazole for three months reduced urinary 3-hydroxypropionic acid and methylmalonic acid. Reducing bacterial propionate production can reduce the burden on the affected pathway, but this study did not establish fewer metabolic crises or better long-term outcomes.
MedicationModest Evidence

Frequently Asked Questions

References

26 studies
  1. Patrick Forny, Friederike Hörster, Diana Ballhausen, Anupam Chakrapani, Kimberly a. Chapman, Carlo Dionisi-vici, Marjorie Dixon, Sarah C. Grünert, Stephanie Grunewald, Goknur Haliloglu, Michel Hochuli, Tomas Honzik, Daniela Karall, Diego Martinelli, Femke Molema, Jörn Oliver Sass, Sabine Scholl-bürgi, Galit Tal, Monique Williams, Martina Huemer, Matthias R. BaumgartnerJournal of Inherited Metabolic Disease2021
  2. Renata C. Gallagher, Laura Pollard, Anna I. Scott, Suzette Huguenin, Stephen Goodman, Qin SunGenetics in Medicine2018
  3. Carolina I. Galarreta Aima, Oleg a. Shchelochkov, Teodoro Jerves Serrano, Charles P. VendittiGenereviews2024
  4. Toshiyuki Ando, Karsten Rasmussen, William L. Nyhan, D. HullProceedings of the National Academy of Sciences1972
  5. Mathilde Nizon, Chris Ottolenghi, Vassili Valayannopoulos, Jean-baptiste Arnoux, Valérie Barbier, Florence Habarou, Isabelle Desguerre, Nathalie Boddaert, Jean-paul Bonnefont, Cécile Acquaviva, Jean-françois Benoist, Daniel Rabier, Guy Touati, Pascale De LonlayOrphanet Journal of Rare Diseases2013

3-Hydroxypropionic Acid Testing Options

$405

See the chemical trail your metabolism leaves behind, and explore where your energy, gut, and nutrient pathways may be under strain.

Includes 49 biomarkers:
3-Hydroxypropionic Acid3-Indoleacetic AcidPhenylacetic AcidDHPPA3-Hydroxyphenylacetic Acid
$509

A comprehensive at-home nutritional and metabolic assessment that analyzes key biomarkers to reveal functional nutrient needs and imbalances.

90 biomarkers
FSA/HSA eligible
No Rx needed
HIPAA compliant